These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3392233)

  • 21. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog.
    Tokuma Y; Fujiwara T; Niwa T; Hashimoto T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):249-62. PubMed ID: 2711027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of nilvadipine in human plasma by capillary column gas chromatography-negative-ion chemical-ionization mass spectrometry.
    Tokuma Y; Fujiwara T; Noguchi H
    J Chromatogr; 1985 Nov; 345(1):51-8. PubMed ID: 4086588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of nifedipine absorption from GITS tablets: comparison of single-dose pharmacokinetics using 10, 20, 40 and 60 mg nifedipine.
    Tateishi T; Okumura K; Orii Y; Tanaka T
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):58-62. PubMed ID: 14756389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on nilvadipine. IV. Synthesis of deuteriated and optically active isopropyl 2-cyano-3-methoxycarbonyl-4-(3-nitrophenyl)-6-methyl-1,4- dihydropyridine-5-carboxylate (nilvadipine).
    Satoh Y; Okumura K; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):950-2. PubMed ID: 8020131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics.
    Harris RZ; Inglis AM; Miller AK; Thompson KA; Finnerty D; Patterson S; Jorkasky DK; Freed MI
    J Clin Pharmacol; 1999 Nov; 39(11):1189-94. PubMed ID: 10579151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nilvadipine in hypertension with renal dysfunction.
    Berger HH; Albert FW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.
    Soons PA; Mulders TM; Uchida E; Schoemaker HC; Cohen AF; Breimer DD
    Eur J Clin Pharmacol; 1993; 44(2):163-9. PubMed ID: 8453961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
    Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
    Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.
    Darwish M; Hellriegel ET
    Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.
    Prevost RR; Akl SA; Whybrew WD; Sibai BM
    Pharmacotherapy; 1992; 12(3):174-7. PubMed ID: 1608848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure.
    van Bortel L; Böhm R; Mooij J; Schiffers P; Rahn KH
    Eur J Clin Pharmacol; 1989; 37(2):185-9. PubMed ID: 2792174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats.
    Takakura S; Furuichi Y; Yamamoto T; Ogawa T; Satoh H; Mori J
    Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nilvadipine increases cerebral blood flow in elderly hypertensives: comparison with nifedipine.
    Shimamoto H; Shimamoto Y
    J Hum Hypertens; 1995 Apr; 9(4):271-9. PubMed ID: 7595910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.